Skip to content
Disclosery

RTW INVESTMENTS, LP

Follow

13F filer, CIK 1493215, NEW YORK, NY

RTW INVESTMENTS, LP reported $11,712,926,784 across 84 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 47.72% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001493215-26-000164

Period
2026-06-30
Reported value
$11.7B
Holdings
84
Top 10 weight
47.72%
New
9
Sold out
13

Largest buys vs the previous quarter

SecurityShares changeApprox. value
KLRAnew+10,776,820$237M
RAREadded+4,148,100$139M
CGONadded+1,529,782$109M
ORKAadded+1,080,882$103M
GPCRnew+1,607,507$86.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
APGEexited-2,782,097-$234M
APLSexited-3,685,045-$148M
COGTreduced-3,149,654-$122M
HNGEreduced-1,430,000-$119M
ISRGexited-220,000-$101M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001493215-26-000164, largest first. % of portfolio is the value over $11,712,926,784, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,993,687 shares; 2024Q4: 1,993,687 shares; 2025Q1: 1,993,687 shares; 2025Q2: 1,993,687 shares; 2025Q3: 1,993,687 shares; 2025Q4: 1,993,687 shares; 2026Q1: 1,993,687 shares; 2026Q2: 1,993,687 shares 1,993,687$1.07B9.14%0Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 654,430 shares; 2024Q4: 673,497 shares; 2025Q1: 673,497 shares; 2025Q2: 673,497 shares; 2025Q3: 673,497 shares; 2025Q4: 673,497 shares; 2026Q1: 709,446 shares; 2026Q2: 709,446 shares 709,446$658M5.62%0Timeline
PTCTPTC THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,393,127 shares; 2024Q4: 7,393,127 shares; 2025Q1: 7,483,127 shares; 2025Q2: 7,746,415 shares; 2025Q3: 7,746,415 shares; 2025Q4: 7,746,415 shares; 2026Q1: 7,746,415 shares; 2026Q2: 7,746,415 shares 7,746,415$632M5.39%0Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 5,426,112 shares; 2024Q4: 5,498,545 shares; 2025Q1: 5,719,415 shares; 2025Q2: 5,756,277 shares; 2025Q3: 5,756,277 shares; 2025Q4: 5,059,053 shares; 2026Q1: 5,059,053 shares; 2026Q2: 5,061,175 shares 5,061,175$620M5.3%+2,122Timeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,344,074 shares; 2024Q4: 1,701,216 shares; 2025Q1: 1,701,216 shares; 2025Q2: 1,701,216 shares; 2025Q3: 1,701,216 shares; 2025Q4: 2,012,127 shares; 2026Q1: 6,984,808 shares; 2026Q2: 8,514,590 shares 8,514,590$605M5.16%+1,529,782Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,272,008 shares; 2024Q4: 3,014,558 shares; 2025Q1: 3,014,558 shares; 2025Q2: 3,084,558 shares; 2025Q3: 3,084,558 shares; 2025Q4: 4,842,879 shares; 2026Q1: 4,842,880 shares; 2026Q2: 4,842,880 shares 4,842,880$516M4.41%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,491,228 shares; 2026Q1: 13,300,620 shares; 2026Q2: 13,900,620 shares 13,900,620$435M3.71%+600,000Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,258,360 shares; 2024Q4: 3,621,996 shares; 2025Q1: 3,621,996 shares; 2025Q2: 3,621,996 shares; 2025Q3: 3,621,996 shares; 2025Q4: 4,171,996 shares; 2026Q1: 4,171,996 shares; 2026Q2: 4,251,996 shares 4,251,996$377M3.22%+80,000Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 550,160 shares; 2026Q1: 3,039,621 shares; 2026Q2: 3,304,903 shares 3,304,903$346M2.95%+265,282Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 146,651 shares; 2026Q1: 16,157,175 shares; 2026Q2: 17,946,754 shares 17,946,754$329M2.81%+1,789,579Timeline
RDNTRADNET INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,808,604 shares; 2024Q4: 1,978,582 shares; 2025Q1: 2,317,582 shares; 2025Q2: 2,690,344 shares; 2025Q3: 2,815,544 shares; 2025Q4: 3,938,500 shares; 2026Q1: 4,285,000 shares; 2026Q2: 4,846,958 shares 4,846,958$299M2.55%+561,958Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,850,648 shares; 2024Q4: 1,945,649 shares; 2025Q1: 1,945,649 shares; 2025Q2: 1,945,649 shares; 2025Q3: 1,945,649 shares; 2025Q4: 2,058,148 shares; 2026Q1: 2,058,148 shares; 2026Q2: 3,139,030 shares 3,139,030$299M2.55%+1,080,882Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,593,323 shares; 2024Q4: 2,593,323 shares; 2025Q1: 2,593,546 shares; 2025Q2: 2,593,645 shares; 2025Q3: 2,000,000 shares; 2025Q4: 1,500,000 shares; 2026Q1: 1,250,000 shares; 2026Q2: 1,000,000 shares 1,000,000$271M2.32%-250,000Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,968,002 shares; 2024Q4: 1,968,002 shares; 2025Q1: 1,707,402 shares; 2025Q2: 1,707,402 shares; 2025Q3: 3,258,266 shares; 2025Q4: 3,000,139 shares; 2026Q1: 3,648,795 shares; 2026Q2: 7,796,895 shares 7,796,895$260M2.22%+4,148,100Timeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,181,990 shares; 2026Q1: 1,668,500 shares; 2026Q2: 2,182,631 shares 2,182,631$260M2.22%+514,131Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,721,158 shares; 2024Q4: 2,721,158 shares; 2025Q1: 2,721,158 shares; 2025Q2: 2,721,158 shares; 2025Q3: 2,721,158 shares; 2025Q4: 2,721,158 shares; 2026Q1: 2,721,158 shares; 2026Q2: 2,862,003 shares 2,862,003$244M2.08%+140,845Timeline
KLRAKAILERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,776,820 shares 10,776,820$237M2.03%newTimeline
ESTAESTABLISHMENT LABS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,645,703 shares; 2024Q4: 2,569,687 shares; 2025Q1: 2,583,887 shares; 2025Q2: 2,584,131 shares; 2025Q3: 2,588,831 shares; 2025Q4: 2,588,831 shares; 2026Q1: 2,655,695 shares; 2026Q2: 2,655,695 shares 2,655,695$228M1.95%0Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 856,501 shares; 2025Q3: 1,481,033 shares; 2025Q4: 1,481,033 shares; 2026Q1: 1,481,033 shares; 2026Q2: 1,481,033 shares 1,481,033$222M1.9%0Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,062,072 shares; 2025Q3: 1,062,072 shares; 2025Q4: 1,062,072 shares; 2026Q1: 1,062,072 shares; 2026Q2: 1,267,925 shares 1,267,925$214M1.82%+205,853Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,412,486 shares; 2024Q4: 3,236,549 shares; 2025Q1: 3,316,032 shares; 2025Q2: 3,111,680 shares; 2025Q3: 3,177,436 shares; 2025Q4: 3,335,320 shares; 2026Q1: 3,346,025 shares; 2026Q2: 3,357,059 shares 3,357,059$211M1.8%+11,034Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,652,285 shares; 2024Q4: 5,123,525 shares; 2025Q1: 5,123,525 shares; 2025Q2: 5,123,525 shares; 2025Q3: 5,123,525 shares; 2025Q4: 5,546,856 shares; 2026Q1: 5,623,525 shares; 2026Q2: 5,623,525 shares 5,623,525$184M1.57%0Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 10,000 shares; 2024Q4: 903,625 shares; 2025Q1: 4,265,428 shares; 2025Q2: 5,158,231 shares; 2025Q3: 4,424,968 shares; 2025Q4: 3,711,462 shares; 2026Q1: 2,586,356 shares; 2026Q2: 3,941,572 shares 3,941,572$182M1.55%+1,355,216Timeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 13,707,506 shares; 2024Q4: 8,705,501 shares; 2025Q1: 8,540,117 shares; 2025Q2: 8,995,547 shares; 2025Q3: 7,144,524 shares; 2025Q4: 7,144,524 shares; 2026Q1: 7,144,524 shares; 2026Q2: 7,144,524 shares 7,144,524$181M1.54%0Timeline
RGENREPLIGEN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,064,000 shares; 2026Q1: 1,206,000 shares; 2026Q2: 1,240,637 shares 1,240,637$169M1.45%+34,637Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,787,347 shares; 2024Q4: 3,834,794 shares; 2025Q1: 3,834,794 shares; 2025Q2: 4,543,895 shares; 2025Q3: 4,543,895 shares; 2025Q4: 4,543,895 shares; 2026Q1: 4,543,895 shares; 2026Q2: 4,543,895 shares 4,543,895$167M1.43%0Timeline
GHRSGH RESEARCH PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,327,129 shares; 2024Q4: 3,327,129 shares; 2025Q1: 5,499,769 shares; 2025Q2: 5,540,457 shares; 2025Q3: 5,569,564 shares; 2025Q4: 5,933,815 shares; 2026Q1: 5,933,815 shares; 2026Q2: 5,933,815 shares 5,933,815$160M1.36%0Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,869,798 shares; 2024Q4: 4,869,798 shares; 2025Q1: 4,869,798 shares; 2025Q2: 4,869,798 shares; 2025Q3: 4,869,798 shares; 2025Q4: 4,869,798 shares; 2026Q1: 4,869,798 shares; 2026Q2: 4,869,798 shares 4,869,798$155M1.32%0Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 3,098,987 shares; 2025Q1: 5,538,168 shares; 2025Q2: 8,221,929 shares; 2025Q3: 8,707,390 shares; 2025Q4: 8,757,390 shares; 2026Q1: 10,632,390 shares; 2026Q2: 10,700,974 shares 10,700,974$151M1.29%+68,584Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 10,000,000 shares; 2024Q4: 6,540,540 shares; 2025Q1: 6,909,510 shares; 2025Q2: 6,970,152 shares; 2025Q3: 8,815,617 shares; 2025Q4: 11,433,354 shares; 2026Q1: 12,869,340 shares; 2026Q2: 12,946,176 shares 12,946,176$131M1.12%+76,836Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 2,509,119 shares; 2025Q1: 3,136,680 shares; 2025Q2: 5,536,876 shares; 2025Q3: 2,291,372 shares; 2025Q4: 6,959,032 shares; 2026Q1: 6,574,032 shares; 2026Q2: 6,574,032 shares 6,574,032$125M1.07%0Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 530,614 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,177,850 shares; 2026Q1: 3,177,849 shares; 2026Q2: 3,177,849 shares 3,177,849$122M1.05%0Timeline
BLTEBELITE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 312,500 shares; 2025Q4: 715,332 shares; 2026Q1: 715,332 shares; 2026Q2: 715,332 shares 715,332$110M0.94%0Timeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 575,000 shares; 2024Q4: 2,402,883 shares; 2025Q1: 2,402,883 shares; 2025Q2: 2,402,883 shares; 2025Q3: 6,221,054 shares; 2025Q4: 6,777,461 shares; 2026Q1: 6,777,461 shares; 2026Q2: 6,777,461 shares 6,777,461$109M0.93%0Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 14,946,420 shares; 2024Q4: 8,672,630 shares; 2025Q1: 18,787,866 shares; 2025Q2: 25,021,584 shares; 2025Q3: 24,354,291 shares; 2025Q4: 16,398,297 shares; 2026Q1: 13,680,248 shares; 2026Q2: 13,560,258 shares 13,560,258$92.3M0.79%-119,990Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,467,486 shares; 2025Q4: 7,592,241 shares; 2026Q1: 5,458,675 shares; 2026Q2: 2,309,021 shares 2,309,021$89.4M0.76%-3,149,654Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 6,654,033 shares; 2024Q4: 7,557,835 shares; 2025Q1: 6,884,698 shares; 2025Q2: 4,682,289 shares; 2025Q3: 1,672,356 shares; 2025Q4: 1,672,356 shares; 2026Q1: 1,672,356 shares; 2026Q2: 1,672,356 shares 1,672,356$87.6M0.75%0Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 125,000 shares; 2024Q4: 125,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,000 shares; 2026Q1: not reported; 2026Q2: 1,607,507 shares 1,607,507$86.3M0.74%newTimeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,133,787 shares; 2024Q4: 2,065,010 shares; 2025Q1: 2,065,010 shares; 2025Q2: 2,065,010 shares; 2025Q3: 6,395,732 shares; 2025Q4: 7,140,352 shares; 2026Q1: 7,356,916 shares; 2026Q2: 7,411,581 shares 7,411,581$82M0.7%+54,665Timeline
CSTLCASTLE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,115,237 shares; 2026Q1: 2,758,335 shares; 2026Q2: 2,778,335 shares 2,778,335$66.3M0.57%+20,000Timeline
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,422,018 shares; 2026Q2: 6,422,018 shares 6,422,018$66.1M0.56%0Timeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 17,687,772 shares; 2024Q4: 17,687,772 shares; 2025Q1: 17,687,772 shares; 2025Q2: 17,687,772 shares; 2025Q3: 17,687,772 shares; 2025Q4: 17,687,772 shares; 2026Q1: 17,687,772 shares; 2026Q2: 17,687,772 shares 17,687,772$60.5M0.52%0Timeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,487,933 shares; 2026Q1: 1,487,934 shares; 2026Q2: 1,487,934 shares 1,487,934$58M0.49%0Timeline
AKTSAKTIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,592,043 shares; 2026Q2: 1,592,043 shares 1,592,043$51.3M0.44%0Timeline
AXGNAXOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,011,576 shares 1,011,576$46.7M0.4%newTimeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 230,000 shares 230,000$43.8M0.37%newTimeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,705,960 shares; 2024Q4: 1,705,960 shares; 2025Q1: 1,705,960 shares; 2025Q2: 1,705,960 shares; 2025Q3: 1,705,960 shares; 2025Q4: 1,705,960 shares; 2026Q1: 1,705,960 shares; 2026Q2: 2,364,347 shares 2,364,347$43.1M0.37%+658,387Timeline
NGNENEUROGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,135,256 shares; 2024Q4: 1,350,256 shares; 2025Q1: 1,348,656 shares; 2025Q2: 1,362,456 shares; 2025Q3: 1,362,456 shares; 2025Q4: 1,362,456 shares; 2026Q1: 1,362,456 shares; 2026Q2: 1,362,456 shares 1,362,456$42.8M0.37%0Timeline
HNGEHINGE HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 353,500 shares; 2026Q1: 1,930,000 shares; 2026Q2: 500,000 shares 500,000$41.5M0.35%-1,430,000Timeline
OBIOORCHESTRA BIOMED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 8,206,159 shares; 2024Q4: 8,206,162 shares; 2025Q1: 8,206,162 shares; 2025Q2: 8,306,062 shares; 2025Q3: 8,306,063 shares; 2025Q4: 8,306,063 shares; 2026Q1: 8,306,063 shares; 2026Q2: 9,556,063 shares 9,556,063$41.2M0.35%+1,250,000Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,892,926 shares 3,892,926$38.9M0.33%newTimeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,952,380 shares; 2026Q1: 5,952,380 shares; 2026Q2: 5,952,380 shares 5,952,380$36.7M0.31%0Timeline
AQSTAQUESTIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,250,000 shares; 2025Q4: 6,250,000 shares; 2026Q1: 7,426,471 shares; 2026Q2: 7,426,471 shares 7,426,471$30.9M0.26%0Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 240,000 shares; 2026Q1: 240,000 shares; 2026Q2: 240,000 shares 240,000$27.5M0.23%0Timeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 4,245,476 shares; 2025Q2: 4,251,616 shares; 2025Q3: 5,426,306 shares; 2025Q4: 6,576,306 shares; 2026Q1: 6,576,306 shares; 2026Q2: 6,635,793 shares 6,635,793$25.3M0.22%+59,487Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 666,667 shares; 2024Q4: 666,667 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 248,063 shares; 2026Q2: 248,063 shares 248,063$24.2M0.21%0Timeline
BBNXBETA BIONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,299,870 shares; 2025Q2: 3,299,191 shares; 2025Q3: 3,299,191 shares; 2025Q4: 2,500,000 shares; 2026Q1: 2,000,000 shares; 2026Q2: 1,500,000 shares 1,500,000$23.5M0.2%-500,000Timeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 8,695,652 shares; 2026Q2: 8,695,652 shares 8,695,652$21.3M0.18%0Timeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,283,671 shares; 2026Q1: 1,502,235 shares; 2026Q2: 1,502,235 shares 1,502,235$20M0.17%0Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 438,659 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 570,394 shares; 2026Q1: 570,394 shares; 2026Q2: 570,394 shares 570,394$19.6M0.17%0Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 300,000 shares; 2026Q2: 400,000 shares 400,000$18.8M0.16%+100,000Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 200,000 shares; 2024Q4: 200,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 370,370 shares 370,370$13.8M0.12%newTimeline
ATAIATAIBECKLEY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,000,000 shares; 2026Q2: 2,000,000 shares 2,000,000$10.5M0.09%0Timeline
MISTMILESTONE PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,256,102 shares; 2024Q4: 2,506,102 shares; 2025Q1: 2,506,102 shares; 2025Q2: 2,506,102 shares; 2025Q3: 2,506,102 shares; 2025Q4: 2,506,102 shares; 2026Q1: 6,331,001 shares; 2026Q2: 7,833,336 shares 7,833,336$10.5M0.09%+1,502,335Timeline
OCGNOCUGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,666,666 shares; 2026Q2: 6,666,666 shares 6,666,666$10.2M0.09%0Timeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 378,346 shares; 2025Q2: 378,346 shares; 2025Q3: 378,346 shares; 2025Q4: 378,346 shares; 2026Q1: 370,246 shares; 2026Q2: 696,570 shares 696,570$10.1M0.09%+326,324Timeline
HTFLHEARTFLOW INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 495,000 shares; 2025Q4: 495,000 shares; 2026Q1: 495,000 shares; 2026Q2: 295,000 shares 295,000$8.66M0.07%-200,000Timeline
FRNMPERCEPTIVE CAP SOLUTIONS CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 742,500 shares; 2024Q4: 742,500 shares; 2025Q1: 742,500 shares; 2025Q2: 742,500 shares; 2025Q3: 742,500 shares; 2025Q4: 742,500 shares; 2026Q1: 742,500 shares; 2026Q2: 742,500 shares 742,500$8.08M0.07%0Timeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 900,000 shares; 2024Q4: 900,000 shares; 2025Q1: 900,000 shares; 2025Q2: 900,000 shares; 2025Q3: 900,000 shares; 2025Q4: 1,350,000 shares; 2026Q1: 1,350,000 shares; 2026Q2: 1,350,000 shares 1,350,000$7.84M0.07%0Timeline
LRMRLARIMAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,125,000 shares; 2025Q4: 3,125,000 shares; 2026Q1: 1,500,000 shares; 2026Q2: 2,565,999 shares 2,565,999$7.83M0.07%+1,065,999Timeline
LMRILUMEXA IMAGING HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 650,000 shares; 2026Q1: 650,000 shares; 2026Q2: 650,000 shares 650,000$7.33M0.06%0Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,250,000 shares 3,250,000$6.76M0.06%newTimeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 372,856 shares; 2026Q1: 372,856 shares; 2026Q2: 372,856 shares 372,856$6.71M0.06%0Timeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 475,737 shares; 2026Q1: 475,737 shares; 2026Q2: 475,737 shares 475,737$6.33M0.05%0Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 212,000 shares 212,000$6.33M0.05%newTimeline
CAPRCAPRICOR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 250,000 shares; 2026Q1: 250,000 shares; 2026Q2: 250,000 shares 250,000$6.02M0.05%0Timeline
KLRSKALARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,300,000 shares; 2026Q1: 1,300,000 shares; 2026Q2: 1,300,000 shares 1,300,000$5.29M0.05%0Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 350,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 26,400 shares 26,400$3.52M0.03%newTimeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 856,962 shares; 2026Q2: 175,000 shares 175,000$3.23M0.03%-681,962Timeline
MDLNMEDLINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 70,000 shares; 2026Q1: 70,000 shares; 2026Q2: 70,000 shares 70,000$2.76M0.02%0Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: 30,000 shares; 2026Q2: 30,000 shares 30,000$2.19M0.02%0Timeline
IMAIMAGENEBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 334,445 shares; 2025Q4: 334,445 shares; 2026Q1: 334,445 shares; 2026Q2: 334,445 shares 334,445$1.97M0.02%0Timeline
XGNEXAGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,511,866 shares; 2024Q4: 1,511,866 shares; 2025Q1: 1,511,866 shares; 2025Q2: 1,696,866 shares; 2025Q3: 1,696,866 shares; 2025Q4: 790,462 shares; 2026Q1: 395,231 shares; 2026Q2: 195,000 shares 195,000$907K0.01%-200,231Timeline
RCKTWROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 350,000 shares; 2024Q4: 350,000 shares; 2025Q1: 350,000 shares; 2025Q2: 350,000 shares; 2025Q3: 350,000 shares; 2025Q4: 350,000 shares; 2026Q1: 350,000 shares; 2026Q2: 350,000 shares 350,000$1.19K<0.01%0Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
APGEAPOGEE THERAPEUTICS INC2,782,097$234Mshares
APLSAPELLIS PHARMACEUTICALS INC3,685,045$148Mshares
ISRGINTUITIVE SURGICAL INC220,000$101Mshares
CNTACENTESSA PHARMACEUTICALS PLC2,054,175$81.6Mshares
CRNXCRINETICS PHARMACEUTICALS IN1,451,326$52.7Mshares
WAYWAYSTAR HLDG CORP1,630,000$39.3Mshares
ARWRARROWHEAD PHARMACEUTICALS IN585,682$36.7Mshares
SYKSTRYKER CORPORATION100,000$32.9Mshares
CMPXCOMPASS THERAPEUTICS INC4,186,599$22.1Mshares
FLGTFULGENT GENETICS INC1,289,000$20.5Mshares
JBIOJADE BIOSCIENCES INC573,205$8.05Mshares
IVAINVENTIVA SA1,298,702$7.21Mshares
OMDAOMADA HEALTH INC200,000$2.51Mshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001493215-26-000164 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001493215-26-000164 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001493215-26-000130 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001493215-26-000060 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001493215-25-000054 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001493215-25-000007 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001493215-25-000003 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001493152-25-006608 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001493152-24-045409 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001493152-24-031911 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001493152-24-019465 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001493152-24-006286 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001493152-23-040729 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001493152-23-028029 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001493152-23-016865 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001493152-23-004608 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001493152-22-032245 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001493152-22-022708 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001493152-22-013567 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001493152-22-004326 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001493152-21-028680 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001493152-21-019742 Quarter ended 2021-06-302021-08-13acceptance time not in the bulk data set
13F-HR 0001493152-21-011440 Quarter ended 2021-03-312021-05-14acceptance time not in the bulk data set
13F-HR 0001493152-21-003922 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR 0001493152-20-021624 Quarter ended 2020-09-302020-11-16acceptance time not in the bulk data set
13F-HR 0001493152-20-015797 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-HR 0001493152-20-009119 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-HR/A 0001493152-20-002551 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-HR 0001493152-20-002338 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-HR 0001493152-19-017406 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001493152-19-012319 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR 0001493152-19-007228 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-HR/A 0001493152-19-002186 Quarter ended 2018-12-312019-02-15acceptance time not in the bulk data set
13F-HR/A 0001493152-19-002190 Quarter ended 2018-12-312019-02-15acceptance time not in the bulk data set
13F-HR 0001493152-19-001927 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-HR 0001493152-18-015906 Quarter ended 2018-09-302018-11-14acceptance time not in the bulk data set
13F-HR 0001493152-18-011640 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR 0001493152-18-006734 Quarter ended 2018-03-312018-05-14acceptance time not in the bulk data set
13F-HR/A 0001493152-18-002731 Quarter ended 2017-12-312018-02-28acceptance time not in the bulk data set
13F-HR 0001493152-18-002062 Quarter ended 2017-12-312018-02-14acceptance time not in the bulk data set
13F-HR 0001493152-17-012995 Quarter ended 2017-09-302017-11-14acceptance time not in the bulk data set
13F-HR 0001493152-17-009184 Quarter ended 2017-06-302017-08-14acceptance time not in the bulk data set
13F-HR 0001493152-17-005309 Quarter ended 2017-03-312017-05-15acceptance time not in the bulk data set
13F-HR 0001493152-17-001592 Quarter ended 2016-12-312017-02-15acceptance time not in the bulk data set
13F-HR/A 0001493152-16-015263 Quarter ended 2016-09-302016-11-18acceptance time not in the bulk data set
13F-HR 0001493152-16-014872 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR 0001493152-16-012354 Quarter ended 2016-06-302016-08-15acceptance time not in the bulk data set
13F-HR/A 0001493152-16-010245 Quarter ended 2015-12-312016-05-24acceptance time not in the bulk data set
13F-HR/A 0001493152-16-010244 Quarter ended 2015-12-312016-05-24acceptance time not in the bulk data set
13F-HR/A 0001493152-16-010243 Quarter ended 2015-09-302016-05-24acceptance time not in the bulk data set
13F-HR 0001493152-16-009638 Quarter ended 2016-03-312016-05-11acceptance time not in the bulk data set
13F-HR 0001493152-16-007396 Quarter ended 2015-12-312016-02-16acceptance time not in the bulk data set
13F-HR 0000909012-15-000338 Quarter ended 2015-09-302015-11-13acceptance time not in the bulk data set
13F-HR 0000909012-15-000277 Quarter ended 2015-06-302015-08-14acceptance time not in the bulk data set
13F-HR 0000909012-15-000223 Quarter ended 2015-03-312015-05-21acceptance time not in the bulk data set
13F-HR 0000919574-15-001784 Quarter ended 2014-12-312015-02-17acceptance time not in the bulk data set